ZNF217 and breast cancer: In this well-described and well-characterized in vivo model, mice injected with ZNF217-positive breast cancer cells developed osteolytic lesions validated by microCT, and only in extremely rare cases were concomitant metastases at other locations observed (Bellanger et al., 2017).